We are live on
!
Find out more
AC
Ascend Capital Portfolio holdings
AUM
$1.99B
1-Year Est. Return
10.36%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.84B
AUM Growth
+$291M
(+11%)
Cap. Flow
+$191M
Cap. Flow
% of AUM
6.72%
Top 10 Holdings %
Top 10 Hldgs %
31.1%
Holding
193
New
73
Increased
29
Reduced
31
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ashland
ASH
|
+$94.9M |
| 2 |
Synchrony
SYF
|
+$65.9M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$52M |
| 4 |
Liberty Global Class A
LBTYA
|
+$50.6M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$49.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$110M |
| 2 |
Golar LNG
GLNG
|
+$64.6M |
| 3 |
Hilton Worldwide
HLT
|
+$60.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$56.9M |
| 5 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$56.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 21.19% |
| 2 | Technology | 16.04% |
| 3 | Healthcare | 13.29% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Energy | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
LSB Industries
LXU
$881M
| $1.67M | 0.06% |
299,948
-228,382
| -43% | -$1.89M |
|
|
ARNA
127
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.56M | 0.05% |
+82,214
| New | +$1.68M |
|
|
HNT
128
DELISTED
HEALTH NET INC
HNT
| $1.51M | 0.05% |
22,078
-53,732
| -71% | -$3.44M |
|
|
BXLT
129
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $1.47M | 0.05% |
37,670
-1,618,727
| -98% | -$56.4M |
|
|
130
Golar LNG
GLNG
$4.95B
| $1.4M | 0.05% |
88,541
-2,527,752
| -97% | -$64.6M |
|
131
Albemarle
ALB
$13.5B
| $1.38M | 0.05% |
24,668
-508,584
| -95% | -$26.2M |
|
|
UNVR
132
DELISTED
Univar Solutions Inc.
UNVR
| $1.27M | 0.04% |
+74,841
| New | +$1.36M |
|
|
NRF
133
DELISTED
NorthStar Realty Finance Corp.
NRF
| $764K | 0.03% |
44,884
-68,779
| -61% | -$1.38M |
|
|
FOMX
134
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $337K | 0.01% |
41,611
-258,389
| -86% | -$1.93M |
|
|
NRE
135
DELISTED
NorthStar Realty Europe Corp.
NRE
| $298K | 0.01% |
+25,240
| New | +$278K |
|
|
VIRX
136
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $186K | 0.01% |
995
| – | – |
|
137
Huntsman Corp
HUN
$2.24B
| $172K | 0.01% |
15,164
-248,836
| -94% | -$2.95M |
|
138
AbbVie
ABBV
$458B
| – | – |
-99,844
| Closed | -$5.75M |
|
|
ADVM
139
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-35,940
| Closed | -$2.96M |
|
140
Ameriprise Financial
AMP
$46.8B
| – | – |
-120,880
| Closed | -$13.2M |
|
141
ASML
ASML
$675B
| – | – |
-540,383
| Closed | -$47.5M |
|
142
Bank of America
BAC
$435B
| – | – |
-708,445
| Closed | -$11M |
|
143
Citigroup
C
$222B
| – | – |
-126,507
| Closed | -$6.28M |
|
144
Cabot Corp
CBT
$4.65B
| – | – |
-305,400
| Closed | -$9.64M |
|
145
Citizens Financial Group
CFG
$30.4B
| – | – |
-226,606
| Closed | -$5.41M |
|
146
ConocoPhillips
COP
$147B
| – | – |
-739,243
| Closed | -$35.5M |
|
147
DigitalBridge
DBRG
$2.94B
| – | – |
-83,905
| Closed | -$4.82M |
|
148
DuPont de Nemours
DD
$18.6B
| – | – |
-157,952
| Closed | -$17M |
|
149
Dine Brands
DIN
$432M
| – | – |
-10,000
| Closed | -$917K |
|
150
Eastman Chemical
EMN
$7.8B
| – | – |
-480,760
| Closed | -$31.1M |
|
Similar funds
MWAC
TP
PC
RW
TBC
BWCA
AC
GCM
Ascend Capital's Q4 2015 Portfolio in Review
As of Q4 2015, Ascend Capital held 193 positions worth $2.84B, up 11% from $2.55B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ascend Capital deployed $191M of net new capital in Q4 2015, opening 73 new positions and adding to 29 existing holdings. Its largest new stake was Ashland: 1,801,800 shares worth $90.5M.
By sector, the portfolio is most concentrated in Communication Services at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Golar LNG, an estimated $64.6M trimmed.
- Ascend Capital's largest Q4 2015 buy was Ashland: 1,801,800 shares worth $90.5M.
- Ascend Capital added most to Liberty Global Class A in Q4 2015, an estimated $50.6M increase.
- Ascend Capital's biggest Q4 2015 reduction was Golar LNG, cutting an estimated $64.6M.
- Ascend Capital fully exited Alphabet (Google) Class C in Q4 2015, selling an estimated $110M.
- Ascend Capital's ten largest holdings make up 31% of its $2.84B portfolio in Q4 2015.
- Ascend Capital opened 73 new positions and closed 51 in Q4 2015.
- Ascend Capital's portfolio value rose 11% quarter-over-quarter to $2.84B.
Based on Ascend Capital's 13F filing for Q4 2015, filed 12 Feb 2016.